Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Med Mal Infect ; 37 Suppl 3: S257-9, 2007 Dec.
Artigo em Francês | MEDLINE | ID: mdl-18054189

RESUMO

The pentavalent antimonial meglumine (Glucantime) is the drug of choice in treatment of cutaneous leishmaniasis in Tunisia. It may create severe adverse effects. A ten year-old girl was treated by Glucantime for cutaneous leishmaniasis. On the eighth day of treatment, she developed palpitations and precordialgia. The ECG showed T wave inversion prolongation of corrected QT interval. Drug therapy was stopped. Within a few days, she recovered and her elctrocardiographic changes came back to normal. The cardio toxicity of Glucantime may be severe. Electrocardiographic changes are the primary signs. Long term ECG follow-up is necessary.


Assuntos
Antiprotozoários/efeitos adversos , Cardiopatias/induzido quimicamente , Meglumina/efeitos adversos , Compostos Organometálicos/efeitos adversos , Criança , Feminino , Humanos , Antimoniato de Meglumina
2.
Arch Fr Pediatr ; 40(10): 815-7, 1983 Dec.
Artigo em Francês | MEDLINE | ID: mdl-6673687

RESUMO

The authors report the results of a study performed in 142 women who gave birth to overgrown neonates. Among them, the incidence of diabetes was high: 7.75%. Older maternal age, maternal obesity and the former birth of large infants were also found to be risk factors for fetal overgrowth.


Assuntos
Peso ao Nascer , Gravidez em Diabéticas , Adulto , Glicemia/análise , Feminino , Humanos , Recém-Nascido , Idade Materna , Paridade , Gravidez , Gravidez em Diabéticas/sangue , Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA